Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece

PCN148 - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS

Value in Health ◽

10.1016/j.jval.2018.09.231 ◽

2018 ◽

Vol 21 ◽

pp. S39-S40

Author(s):

N. Kourkoulas ◽

K. Athanasakis ◽

M. Kakouros ◽

A. Skroumpelos ◽

J. Kyriopoulos

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Treatment Options ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece

Value in Health ◽

10.1016/j.jval.2017.08.233 ◽

2017 ◽

Vol 20 (9) ◽

pp. A439 ◽

Cited By ~ 1

Author(s):

N Kourkoulas ◽

D Kyriopoulos ◽

K Athanasakis

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Standard Of Care ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

PCN76 A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN PORTUGAL

Value in Health ◽

10.1016/j.jval.2019.09.273 ◽

2019 ◽

Vol 22 ◽

pp. S450

Author(s):

B. Pinheiro ◽

L. Silva Miguel ◽

J. Alarcão ◽

N. Paracha ◽

F. Felizzi ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Effectiveness Analysis ◽

Previously Treated

PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN BELGIUM

Value in Health ◽

10.1016/j.jval.2018.09.259 ◽

2018 ◽

Vol 21 ◽

pp. S44

Author(s):

K. Moeremans ◽

L. Van Bellinghen ◽

T. De Celle ◽

B. Quintens ◽

N. Paracha

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Effectiveness Analysis ◽

Previously Treated

PCN145 COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB IN ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER AFTER CONCURRENT PLATINUM-BASED CHEMORADIATION IN FRANCE

Value in Health ◽

10.1016/j.jval.2019.09.341 ◽

2019 ◽

Vol 22 ◽

pp. S463

Author(s):

A. Tetafort ◽

H. Haug ◽

C. Le Péchoux ◽

C. Chouaid ◽

A. Gherardi ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Adult Patients ◽

Small Cell Lung ◽

Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada

PharmacoEconomics ◽

10.1007/s40273-021-01022-9 ◽

2021 ◽

Author(s):

Yong-Jin Kim ◽

Mark Oremus ◽

Helen H. Chen ◽

Thomas McFarlane ◽

Danielle Fearon ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Cancer Management and Research ◽

10.2147/cmar.s223441 ◽

2019 ◽

Vol Volume 11 ◽

pp. 9195-9202 ◽

Cited By ~ 3

Author(s):

Maobai Liu ◽

Longfeng Zhang ◽

Qishu Huang ◽

Na Li ◽

Bin Zheng ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Cost-Effectiveness of Eml4-Alk Gene Targeted First-Line Ceritinib Treatment Among Patients With Advanced Alk-Positive Non–Small Cell Lung Cancer

Value in Health ◽

10.1016/j.jval.2015.03.1177 ◽

2015 ◽

Vol 18 (3) ◽

pp. A203

Author(s):

N. Upadhyay ◽

N. Atreja

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Alk Positive

Cost-effectiveness Analysis of Robotic-assisted Lobectomy for Non-small Cell Lung Cancer

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2021.06.090 ◽

2021 ◽

Author(s):

Brendan T. Heiden ◽

Joshua D. Mitchell ◽

Eric Rome ◽

Varun Puri ◽

Bryan F. Meyers ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Robotic Assisted ◽

A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

Value in Health Regional Issues ◽

10.1016/j.vhri.2018.05.001 ◽

2019 ◽

Vol 18 ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Xinyan Li ◽

Weichen Li ◽

Lingping Hou

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽